share_log

ImmunoPrecise Antibodies Q1 Sales $4.70M Beat $4.02M Estimate

ImmunoPrecise Antibodies Q1 Sales $4.70M Beat $4.02M Estimate

免疫精抗體第一季度銷售額470萬美元超過預期402萬美元
Benzinga Real-time News ·  2022/09/14 08:08

ImmunoPrecise Antibodies (NASDAQ:IPA) reported quarterly sales of $4.70 million which beat the analyst consensus estimate of $4.02 million by 16.92 percent. This is a 25.87 percent increase over sales of $3.73 million the same period last year.

免疫精抗體公司(納斯達克代碼:IPA)公佈季度銷售額為470萬美元,比分析師一致預期的402萬美元高出16.92%。這比去年同期373萬美元的銷售額增長了25.87%。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論